Aug 11 (Reuters) -
BOEHRINGER INGELHEIM SAYS EACH 60-TABLET BOTTLE OF ITS APPROVED LUNG CANCER TREATMENT, HERNEXEOS, IS $21,667.01
BOEHRINGER INGELHEIM SAYS GOAL IS TO MAKE HERNEXEOS AVAILABLE TO PATIENTS AS SOON AS THEY RECEIVE PRESCRIPTION FROM THEIR HEALTHCARE PROVIDER